Can Focal Segmental Glomerulosclerosis Be Differentiated From Minimal Change Nephrotic Syndrome Using Biomarkers?

Am J Med Sci. 2018 Apr;355(4):305-306. doi: 10.1016/j.amjms.2018.01.003. Epub 2018 Jan 31.

Author

Keiko Hosohata¹

Affiliation

¹ Education and Research Center for Clinical Pharmacy Osaka University of Pharmaceutical Sciences Takatsuki, Osaka, Japan. Electronic address: hosohata@gly.oups.ac.jp.

PMID: 29661342
DOI: 10.1016/j.amjms.2018.01.003

No abstract available

Publication types

Editorial

MeSH terms

Biomarkers / urine
Diagnosis, Differential
Glomerulosclerosis, Focal Segmental / urine*
Humans
Lipocalin-2 / urine*
Nephrotic Syndrome / urine*

Substances

Biomarkers
LCN2 protein, human
Lipocalin-2